Chemotherapy for large-cell lymphoma: optimism and caution.
about
Interpreting outcome data in hematological malignancies: a paradigm for clinical studiesInduction of the WAF1/CIP1 protein and apoptosis in human T-cell leukemia virus type I-transformed lymphocytes after treatment with adriamycin by using a p53-independent pathway.Evidence of an association between non-Hodgkin's lymphoma and skin cancer.Semantics and the chemotherapy of Hodgkin's disease--resistance is not relapse: alternative chemotherapy lacks effectiveness for disease not totally responsive to initial MOPP treatment.Treatment of aggressive non-Hodgkin' lymphomas. Lessons from the past 10 years.Bone marrow involvement, in intensively treated patients with intermediate grade non-Hodgkin's lymphoma, is a risk factor for granulocytopenia and fever.Adding high-dose tamoxifen to CHOP does not influence response or survival in aggressive non-Hodgkin's lymphoma: an interim analysis of a randomized phase III trial.Toxicity and preliminary results with a new eight-drug regimen (CEOP-IMVP-DEXA) in the treatment of aggressive lymphomas.Cyclophosphamide, vincristine, adriamycin, and prednisone (CHOP) with and without intermediate dose methotrexate for the treatment of non-Hodgkin's lymphomas of diffuse histology.Non-Hodgkin's lymphoma of unfavourable histology: a multivariate analysis of factors predicting the response to CHOP.MACOP-B vs F-MACHOP regimen in the treatment of high-grade non-Hodgkin's lymphomas.T-cell phenotype is associated with decreased survival in non-Hodgkin's lymphoma.
P2860
Q30658847-154AEF50-5FDF-4E1F-9941-84A10F45E7ACQ33615239-A904F4F4-23D4-4515-989F-82BB2C0A827FQ36903853-B6209CA9-A5F7-44E2-996D-605D186EA2AFQ38487517-82B7F302-5FE0-4668-84DE-37BDD84BCFCCQ40394117-B40A258C-5252-4B57-8974-201906D24E22Q40676004-31036E84-F19F-4A09-8A8A-71F74C05DBF4Q40774302-F94965B7-DEF3-486C-9D7C-90B1DB81CE5FQ41866545-BB6BD63D-6D7D-436B-8FC8-A86871E8E46FQ44303319-764EDD2B-F43A-457D-AF2A-2E9A5D3D3BA3Q52592912-9480B15B-1567-4DE2-907D-052C8597901DQ54182149-DA2D3848-CDB6-46C3-8305-0AE48F44D8F9Q55242219-C52EBE3D-939B-4D10-AC31-C5C8B4F15CF4
P2860
Chemotherapy for large-cell lymphoma: optimism and caution.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh-hant
name
Chemotherapy for large-cell lymphoma: optimism and caution.
@en
Chemotherapy for large-cell lymphoma: optimism and caution.
@nl
type
label
Chemotherapy for large-cell lymphoma: optimism and caution.
@en
Chemotherapy for large-cell lymphoma: optimism and caution.
@nl
prefLabel
Chemotherapy for large-cell lymphoma: optimism and caution.
@en
Chemotherapy for large-cell lymphoma: optimism and caution.
@nl
P1476
Chemotherapy for large-cell lymphoma: optimism and caution.
@en
P2093
P304
P356
10.7326/0003-4819-103-1-140
P407
P577
1985-07-01T00:00:00Z